Navigation Links
Octapharma Accepting Applications for Research Grants Focused on Human Protein Therapies
Date:10/14/2010

over 27 years. Octapharma's core business is the development, production and sale of high quality human protein therapies from both human plasma and human cell-lines, including immune globulin intravenous (IGIV). In the U.S., Octapharma's IGIV product, octagam® (immune globulin intravenous [human] 5%), is used to treat disorders of the immune system, and Octapharma's Albumin (Human)® is indicated for the restoration and maintenance of circulating blood volume. Octapharma's wilate® received orphan drug exclusivity from the U.S. Food and Drug Administration (FDA) for the treatment of von Willebrand disease (VWD). Octapharma employs over 4,000 people and has biopharmaceutical experience in 80 countries worldwide, including the United States, where Octapharma USA is located in Hoboken, N.J.  Octapharma operates two state-of-the-art production sites licensed by the FDA, providing a high level of production flexibility. For more information, please visit www.octapharma.com.


'/>"/>
SOURCE Octapharma USA
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Octapharma USA Launches Web Resource for von Willebrand Disease Healthcare Professionals and Patients
2. FDA Confirms Orphan Drug Exclusivity Approval for wilate®, Octapharma USAs New Therapy for Common Inherited Bleeding Disorder
3. Octapharma USA Announces Availability and Distributors for wilate®, the First Replacement Therapy Developed Specifically for von Willebrand Disease
4. Octapharma Receives Orphan Drug Exclusivity Approval for wilate(R) - A Replacement Therapy Developed Specifically for von Willebrand Disease
5. Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease
6. Octapharma Group and Fresenius Kabi Enter Into an Exclusive License, Development and Supply Agreement for a HESylated Recombinant Protein
7. Octapharma Targeting the Major Risk of Hemophilia Treatment - FVIII Antibodies
8. Octapharma Accepting Applications for Research Grants on Immunotherapy, Coagulation Disorders and Critical Care
9. Plasma Products Safe Despite Swine Influenza Outbreak, Assures International Biopharmaceutical Company Octapharma
10. Cannabis Science Issues Guidance on Its Progress Toward FDA Investigative New Drug Applications For Clinical Trials and Proposed Dividend Payout for Current Shareholders to Receive a New Class of Common Stock
11. Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 27, 2015  PTC Therapeutics, Inc. (NASDAQ: ... financial results for the fourth quarter and full year ... a transformative year for PTC. We are now a ... RNA-targeted therapies in the rare disease space," stated Stuart ... "We are proud to bring the first treatment for ...
(Date:2/27/2015)... JERUSALEM , Feb. 27, 2015 /PRNewswire/ ... capsules, its lead product for the orphan condition acromegaly, ... E financing round. Participants in the financing included new ... undisclosed blue chip public investment fund, as well as ... Ventures, Abingworth and ARCH Venture Partners. ...
(Date:2/26/2015)... CHICAGO, Ill. , Feb. 26, 2015 /PRNewswire/ ... that 15 abstracts of studies in its neuroscience ... presentation during the 67 th American Academy ... D.C. , from April 18-25. The accepted ... product, DUOPA, in addition to investigational treatments in ...
Breaking Medicine Technology:PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 10PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 11Chiasma Announces Completion of $70 Million Series E Financing 2Chiasma Announces Completion of $70 Million Series E Financing 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 2AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 4AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 5AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 6AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 7
... grant awarded by NIH; Findings could benefit,pregnant women ... Institute of,Child Health and Human Development division of ... A. Williams, Sc.D., a $2.9 million grant,for a ... the,serious pregnancy complication known as preeclampsia and migraine., ...
... of cost-effective and rapidly deployed ... vaccine solution for avian and seasonal flu, ROCKVILLE, ... announced today its recognition at the annual meeting of ... an H5N1 avian influenza vaccine and a seasonal influenza ...
Cached Medicine Technology:Swedish in Seattle to Study Connections Between Preeclampsia and Migraine 2Swedish in Seattle to Study Connections Between Preeclampsia and Migraine 3NOVAVAX Featured at Clinton Global Initiative 2008 Annual Meeting 2NOVAVAX Featured at Clinton Global Initiative 2008 Annual Meeting 3
(Date:3/1/2015)... ERISAPros is pleased to ... to the professional staff of its Compliance Department. , ... Ohio State University-Mortiz College of Law. Prior to joining ... with several Fortune 500 companies as well as several ... benefits. Her experiences range from benefit plan design, vendor ...
(Date:3/1/2015)... WA (PRWEB) February 28, 2015 CrossFit Attollo ... spring they are offering a special discount to new members. ... sign up for a three month contract will receive their ... month individually would cost members $440. The three month ... per month, and then the fourth month comes in at ...
(Date:2/28/2015)... 01, 2015 Heart diseases are on ... percent of urban adult population and 5 percent of ... diseases and 20-30 percent of them require specialized investigation ... and coronary vascular diseases (CVD). , A division of ... market research report titled “Indian Coronary Stent Market Forecast ...
(Date:2/28/2015)... 2015 With their commitment to achieving ... an additional exercise to their already robust library of ... most commonly known as, is often performed on a ... executed in a relatively safe manner and can be ... The full description of “Rope Pulls” is located in ...
(Date:2/28/2015)... 28, 2015 March—also known as ... to remind ourselves and others that suspected head ... NeuroSurgical Specialists (ANS). , Concussions are a form ... 75% of TBIs. There are 1.6-3.8 million sports-related ... benign, but it is a brain injury. Many ...
Breaking Medicine News(10 mins):Health News:ERISAPros Recruits Evelyn King, J.D. and Carolyn Roddy, J.D. to its Professional Staff 2Health News:CrossFit Gym in Vancouver WA Offers Spring Special 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 3Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 3
... patients with a form of epilepsy , , TUESDAY, Oct. ... associated with a high risk for complications and even death ... researchers at the Mayo Clinic in Rochester, Minn. , The ... prolonged seizures that don,t respond to initial treatment. The condition ...
... lung cancer called video-assisted thoracic surgery or VATS is ... centers. Now, a preliminary study to be presented ... is giving surgeons an early look at its benefits. ... a six to 10-inch incision, cutting the major muscles ...
... "They said one pink,bus couldn,t change a ... for,Breast Health Education,s message on the side of ... starting next week. The bus will promote the,"Size ... http://www.newscom.com/cgi-bin/prnh/20081028/DC42054 ), October is National ...
... 2008A team of Universit Laval researchers has shown that the ... brains of mice fed a diet rich in animal fat ... diets typical of most industrialized countries promote the development of ... of Aging . , To demonstrate this, the team led ...
... annual mammograms and breast self-examination during National Breast Cancer Awareness ... cautious when getting a mammogram. , ... ... premier online destination for personal image enhancement solutions, is pleased ...
... Society of Plastic Surgeons Annual Meeting, CHICAGO, ... born with a rare congenital deformity who turned ... the proud recipient of,the 2008 Patients of Courage: ... Plastic Surgeons (ASPS) Plastic Surgery 2008 conference,Saturday, November ...
Cached Medicine News:Health News:Sedative Could Be Deadly in People With Seizures 2Health News:Highly specialized, minimally invasive surgery for lung cancer allows patient to go home sooner 2Health News:The Maurer Foundation Promotes Breast Health Message With Unique Traveling Pink Bus 2Health News:A high-fat diet could promote the development of Alzheimer's 2Health News:Women with Breast Implants Encouraged To Go Beyond Regular Mammogram Screening 2Health News:Women with Breast Implants Encouraged To Go Beyond Regular Mammogram Screening 3Health News:Women with Breast Implants Encouraged To Go Beyond Regular Mammogram Screening 4Health News:Towson Student Wins Courage Award, Turns Facial Differences Into Positive Tool 2
Gold Labeling kit for antibodies, the Coat-Block-Run Conjugation Kit pH 5-8; contains 1 bottle each of 20 nm and 40 nm Naked Gold...
Colloidal Gold Conjugated, Goat anti-mouse IgG (H&L) - 12 OD...
Colloidal Gold Conjugated, Goat anti-mouse IgG (H&L) - 50 OD...
Colloidal Gold Conjugated, Goat anti-human IgM (Mu Chain) - 12 OD...
Medicine Products: